Clinical Trials on Anti-D Antibodies in Belgium
Total 26 results
-
University of LiegeCompletedBurn Injury | Vitamin DBelgium
-
PENTA FoundationKing's College Hospital NHS Trust; Karolinska Institutet; Hospital General Universitario... and other collaboratorsRecruitingSars-Cov2 Antibodies in Children and Adolescents Living With HIVSpain, United Kingdom, South Africa, Belgium, Greece, Ukraine
-
Universitaire Ziekenhuizen KU LeuvenUnknown
-
Universitair Ziekenhuis BrusselCompleted
-
Universitair Ziekenhuis BrusselCompleted
-
Universitaire Ziekenhuizen KU LeuvenLaboratoires TheaCompletedAge-related Macular Degeneration | Vitamin D DeficiencyBelgium
-
Université Catholique de LouvainRecruitingPharmacokinetics | Infection | Infection, Bacterial | Anti-Bacterial Agents | Drug Monitoring | Infections, RespiratoryBelgium
-
Cliniques universitaires Saint-Luc- Université...UnknownVitamin D Deficiency | Generalized Chronic PeriodontitisBelgium
-
Universitaire Ziekenhuizen KU LeuvenGEOMAR-Helmholtz Centre for Ocean ResearchCompletedBone Diseases | Osteoporosis | OsteomalaciaBelgium, Germany
-
HepNet Study House, German LiverfoundationHannover Medical School; German Center for Infection ResearchCompletedHepatitis DGermany, Austria, Belgium, Brazil, Georgia, Greece, Italy, Moldova, Republic of, Pakistan, Romania, Spain, Vietnam
-
Medical University of GrazMedical University of Vienna; University Hospital, Essen; Goethe University; Guy... and other collaboratorsRecruitingCritical Illness | Covid19 | Vitamin D DeficiencyAustria, Belgium
-
Eiger BioPharmaceuticalsActive, not recruitingHepatitis Delta VirusUnited States, France, Belgium, Spain, Italy, Turkey, Bulgaria, Germany, Israel, Romania, Georgia, Moldova, Republic of
-
Eiger BioPharmaceuticalsCompletedHepatitis Delta VirusUnited States, Belgium, Spain, Greece, Canada, Italy, Romania, Germany, Israel, Bulgaria, Taiwan, Turkey, Pakistan, Sweden, Ukraine, New Zealand, Russian Federation, United Kingdom, Moldova, Republic of, France, Mongolia, Switzerland
-
ChemoCentryxCompletedA Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis (ADVOCATE)ANCA-Associated VasculitisUnited States, Australia, Belgium, Canada, France, Italy, Japan, Netherlands, Spain, United Kingdom, Austria, Czechia, Denmark, Germany, Hungary, Ireland, New Zealand, Norway, Sweden, Switzerland
-
Human Genome Sciences Inc., a GSK CompanyGlaxoSmithKlineCompletedVasculitisUnited States, Australia, France, Spain, Italy, Peru, Belgium, Canada, Germany, Romania, Mexico, United Kingdom, Hungary, Ireland, Poland, Switzerland, Czechia, Russian Federation, Norway, Sweden
-
AstraZenecaActive, not recruitingEosinophilic Granulomatous VasculitisUnited States, Canada, France, Italy, Israel, United Kingdom, Japan, Germany, Belgium
-
GlaxoSmithKlineNational Institute of Allergy and Infectious Diseases (NIAID)CompletedA Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With PolyangiitisChurg-Strauss SyndromeUnited States, France, Japan, Spain, Italy, Germany, Canada, Belgium, United Kingdom
-
InflaRx GmbHCompletedGranulomatosis With Polyangiitis (GPA) | Microscopic Polyangiitis (MPA)Germany, Russian Federation, Belgium, France, Spain, Czechia, Italy, Netherlands, Sweden, Switzerland, United Kingdom
-
GlaxoSmithKlineCompletedChurg-Strauss Syndrome | Eosinophilic Granulomatosis With PolyangiitisUnited States, France, Japan, Germany, Canada, United Kingdom, Belgium
-
Centre Hospitalier Universitaire de LiegeSanofi; Takeda; University of Liege; Orchard Therapeutics; Centre Hospitalier Régional... and other collaboratorsRecruitingCongenital Adrenal Hyperplasia | Hemophilia A | Hemophilia B | Mucopolysaccharidosis I | Mucopolysaccharidosis II | Cystic Fibrosis | Alpha 1-Antitrypsin Deficiency | Sickle Cell Disease | Fanconi Anemia | Chronic Granulomatous Disease | Wilson Disease | Severe Congenital Neutropenia | Ornithine Transcarbamylase... and other conditionsBelgium
-
Scholar Rock, Inc.Active, not recruitingNeuromuscular Diseases | Neuromuscular Manifestations | Atrophy | Muscular Atrophy | Spinal Muscular Atrophy | Muscular Atrophy, Spinal | Spinal Muscular Atrophy Type 3 | SMA | Anti-myostatin | Spinal Muscular Atrophy Type IIUnited States, Spain, Belgium, Germany, Netherlands, Poland, Italy, France, United Kingdom
-
Scholar Rock, Inc.Active, not recruitingNeuromuscular Diseases | Neuromuscular Manifestations | Atrophy | Muscular Atrophy | Spinal Muscular Atrophy | Muscular Atrophy, Spinal | Spinal Muscular Atrophy Type 3 | SMA | Spinal Muscular Atrophy Type 2 | Anti-myostatinUnited States, Germany, Belgium, Spain, United Kingdom, Netherlands, France, Italy, Poland
-
University of PennsylvaniaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedMicroscopic Polyangiitis (MPA) | Granulomatosis With Polyangiitis (Wegener's) (GPA)United States, Belgium, France, United Kingdom, Denmark, Canada, Japan, Australia, New Zealand, Sweden, Czechia, Italy, Greece, Mexico, Norway
-
GlaxoSmithKlineRecruitingEosinophilic Granulomatosis With PolyangiitisCanada, France, Italy, Spain, Belgium, Korea, Republic of, United States, Japan, China, Czechia, Hungary, Israel, Portugal, Poland, Netherlands, United Kingdom, Austria, Argentina, Australia, Brazil, Germany, Sweden
-
Kyowa Kirin Pharmaceutical Development LtdActive, not recruitingX-Linked HypophosphatemiaSpain, Italy, United Kingdom, France, Belgium, Denmark, Germany, Hungary, Portugal, Norway, Switzerland, Israel, Netherlands, Czechia, Bulgaria, Sweden, Slovenia, Ireland, Latvia, Slovakia
-
University of OxfordAmerican College of Rheumatology; The European League Against Rheumatism (EULAR) and other collaboratorsUnknownGiant Cell Arteritis | Wegener's Granulomatosis | Microscopic Polyangiitis | Polyarteritis Nodosa | Takayasu Arteritis | Churg Strauss SyndromeKorea, Republic of, United States, Germany, Australia, Japan, Ireland, Belgium, Italy, Denmark, Slovenia, Switzerland, Canada, Argentina, Austria, China, Czech Republic, Egypt, Finland, France, Hungary, India, Mexico, Netherlands, New... and more